title: Rheumatoid arthritis: Manipulating the FLS 'proteoglycan switch' could offer a new approach to RA therapy.
authors.forename: Sarah
authors.initials: S
authors.lastname: Onuora
mesh_terms: D000818:Animals; D018501:Antirheumatic Agents / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000517:prevention & control*; D011508:Chondroitin Sulfate Proteoglycans / Q000378:metabolism*; D006493:Heparin / Q000031:analogs & derivatives*; D006801:Humans; D011509:Proteoglycans / Q000378:metabolism*; D054623:Receptor-Like Protein Tyrosine Phosphatases, Class 2 / Q000037:antagonists & inhibitors*; D013583:Synovial Membrane / Q000187:drug effects*
chemical_list: D018501:Antirheumatic Agents; D011508:Chondroitin Sulfate Proteoglycans; D011509:Proteoglycans; D006493:Heparin; D054623:Receptor-Like Protein Tyrosine Phosphatases, Class 2